Brief: Gracell Biotechnologies Reports Third Quarter 2022 Unaudited Financial Results And Provides Corporate Update
14/11/2022 13:39
Nov 14 (Reuters) - Gracell Biotechnologies Inc GRCL.O :
* GRACELL BIOTECHNOLOGIES REPORTS THIRD QUARTER 2022
UNAUDITED
FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
* WELL-FUNDED WITH CASH RUNWAY FOR NEXT 24 MONTHS
* QTRLY NET LOSS PER SHARE ATTRIBUTABLE TO GRACELL
BIOTECHNOLOGIES
INC'S ORDINARY SHAREHOLDERS RMB 0.51
* Q3 EARNINGS PER SHARE VIEW $-0.13 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX2XStVq
Further company coverage: GRCL.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Gracell Biotechnologies
See all newsBrief: Gracell Biotechnologies Announces Shareholders’ Approval Of Merger Agreement
Brief: Gracell Biotechnologies Announces FDA Clearance of IND Application for Phase 1 Clinical Trial of FasTCAR-T GC012F as Early-Line Treatment of Multiple Myeloma
Newscasts - UK Day Ahead: European shares start last week of 2023 on strong footing
Live Markets: European futures rise after holiday break
Press Digest: British Business - Dec 27